Recently, improvement of lipid accumulation, assessed by liver proton magnetic resonance spectroscopy (1H-MRS), has been shown in patients with T2DM treated with GLP-1 agonists [21]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.